ICMR seeks industry partners for Nipah virus monoclonal antibody production

Scientists in India are looking for help from local companies to make special medicines called monoclonal antibodies.

These medicines are like superhero proteins that can fight off the dangerous Nipah virus.

The Nipah virus is very serious and has caused sickness in India before.

Even though there are no approved vaccines or medicines for it yet, these monoclonal antibodies have shown good results in animal studies.

They can help protect people who might have been exposed to the virus, like healthcare workers.

Making these antibodies in India means they can be ready quickly if there's an outbreak.

This will help the country be better prepared to fight this deadly disease.